USE OF A PHOTOSENSITIVE AGENT CAPABLE OF PRODUCING REACTIVE OXYGEN SPECIES IN THE PRODUCTION OF A DRUG FOR THE PHOTODYNAMIC THERAPY OF A DISEASE RELATED TO STEM CELLS, IN VITRO USE, AND PHARMACEUTICAL COMPOSITION

摘要

The invention relates to the use of a photosensitive agent, or the precursor thereof, capable of producing reactive oxygen species (ROS) in the production of a drug that can be used for the photodynamic therapy (PDT)-based treatment of a disease related to a patient's stem cells, preferably epidermal stem cells.